248 related articles for article (PubMed ID: 22496212)
1. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses.
Zhou F; Wang G; Buchy P; Cai Z; Chen H; Chen Z; Cheng G; Wan XF; Deubel V; Zhou P
J Virol; 2012 Jun; 86(12):6970-8. PubMed ID: 22496212
[TBL] [Abstract][Full Text] [Related]
2. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
[TBL] [Abstract][Full Text] [Related]
3. Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
Li H; Sun H; Tao M; Han Q; Yu H; Li J; Lu X; Tong Q; Pu J; Sun Y; Liu L; Liu J; Sun H
J Virol; 2024 Mar; 98(3):e0112923. PubMed ID: 38305155
[TBL] [Abstract][Full Text] [Related]
4. Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
Nuñez IA; Ross TM
Vaccine; 2020 Jan; 38(4):830-839. PubMed ID: 31733946
[TBL] [Abstract][Full Text] [Related]
5. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
[TBL] [Abstract][Full Text] [Related]
6. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
7. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
Wang G; Zhou F; Buchy P; Zuo T; Hu H; Liu J; Song Y; Ding H; Tsai C; Chen Z; Zhang L; Deubel V; Zhou P
J Infect Dis; 2014 Mar; 209(5):676-85. PubMed ID: 23911711
[TBL] [Abstract][Full Text] [Related]
8. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
[TBL] [Abstract][Full Text] [Related]
9. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.
Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G
Front Immunol; 2019; 10():2006. PubMed ID: 31552018
[TBL] [Abstract][Full Text] [Related]
10. Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.
Tsai C; Caillet C; Hu H; Zhou F; Ding H; Zhang G; Zhou B; Wang S; Lu S; Buchy P; Deubel V; Vogel FR; Zhou P
Vaccine; 2009 Nov; 27(48):6777-90. PubMed ID: 19732860
[TBL] [Abstract][Full Text] [Related]
11. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
Hu H; Voss J; Zhang G; Buchy P; Zuo T; Wang L; Wang F; Zhou F; Wang G; Tsai C; Calder L; Gamblin SJ; Zhang L; Deubel V; Zhou B; Skehel JJ; Zhou P
J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297
[TBL] [Abstract][Full Text] [Related]
12. Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens.
Stachyra A; Redkiewicz P; Kosson P; Protasiuk A; Góra-Sochacka A; Kudla G; Sirko A
Virol J; 2016 Aug; 13(1):143. PubMed ID: 27562235
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
Front Immunol; 2021; 12():692700. PubMed ID: 34335603
[TBL] [Abstract][Full Text] [Related]
14. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
[TBL] [Abstract][Full Text] [Related]
15. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
[TBL] [Abstract][Full Text] [Related]
16. A single electroporation delivery of a DNA vaccine containing the hemagglutinin gene of Asian H5N1 avian influenza virus generated a protective antibody response in chickens against a North American virus strain.
Ogunremi O; Pasick J; Kobinger GP; Hannaman D; Berhane Y; Clavijo A; van Drunen Littel-van den Hurk S
Clin Vaccine Immunol; 2013 Apr; 20(4):491-500. PubMed ID: 23365205
[TBL] [Abstract][Full Text] [Related]
17. Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.
Ding H; Tsai C; Zhou F; Buchy P; Deubel V; Zhou P
PLoS One; 2011 Mar; 6(3):e17821. PubMed ID: 21464977
[TBL] [Abstract][Full Text] [Related]
18. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.
Furey C; Scher G; Ye N; Kercher L; DeBeauchamp J; Crumpton JC; Jeevan T; Patton C; Franks J; Rubrum A; Alameh MG; Fan SHY; Phan AT; Hunter CA; Webby RJ; Weissman D; Hensley SE
Nat Commun; 2024 May; 15(1):4350. PubMed ID: 38782954
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.
Prabakaran M; He F; Meng T; Madhan S; Yunrui T; Jia Q; Kwang J
J Virol; 2010 Nov; 84(22):11822-30. PubMed ID: 20844051
[TBL] [Abstract][Full Text] [Related]
20. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]